4 results
The primary objective is to test the feasibility (Study 1) and the effectiveness (Study 2) of using self-tracking device and web-based coaching platform to increase PA levels among patients in the early CR process. Effectiveness of the new approach…
To assess which treatment leads to the best patient outcome on the short term (1 year) and the long term (5 years)
To evaluate the long-term safety of zanubrutinib in patients with B-cell cancers who participated in a BeiGene parent study for zanubrutinib
All primary and secondary objectives will compare zanubrutinib (also known as BGB-3111) plus rituximab followed by zanubrutinib monotherapy versus bendamustine plus rituximab followed by observation only.Primary:• To compare efficacy, as measured by…